SM-020

N/A

Report date: 2024/08/16 15:21:29
NME

Base Information

Drug NameSM-020
Drug Alias NameSM-020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene proteins c-akt inhibitors
TargetsProto-oncogene proteins c-akt
Therapy Area/IndicationsKeratosis, SeborrheicSkin DiseasesSkin Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEl Salvador
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeylanMED LLC
China Registration ClassN/A

Develop Information

Active CompaniesDermbiont IncSeylanMED LLC
Inactive CompaniesN/A
Active IndicationsKeratosis, SeborrheicSkin DiseasesSkin Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A